Cover Image
市場調查報告書

呼吸輔助設備的全球市場:醫療設備的開發平台評估

Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 361020
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
Back to Top
呼吸輔助設備的全球市場:醫療設備的開發平台評估 Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年02月15日 內容資訊: 英文 77 Pages
簡介

本報告提供全球呼吸輔助配件市場上主要的開發中產品與其臨床實驗的進展調查,彙整產品功能、特性比較分析 (臨床實驗的各進行階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 呼吸輔助設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各部門
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 呼吸輔助設備的企業:各臨床實驗階段的開發中產品
  • 呼吸輔助設備:各臨床實驗階段的開發中產品

第5章 呼吸輔助設備市場:企業·產品概要

  • ALung Technologies, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Breethe, Inc.
  • Case Western Reserve University
  • Haemair Limited
  • Liberate Medical, LLC
  • Lung Biotechnology PBC
  • McGowan Institute for Regenerative Medicine
  • MedArray Inc.
  • Merit Medical Systems, Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc.
  • Pneumedicare Ltd.
  • Rice University
  • The Charles Stark Draper Laboratory Inc
  • University of Arizona
  • University of California, Los Angeles
  • University of California, San Francisco
  • University of Kansas
  • University of Pittsburgh
  • Xenios AG

第6章 縫合線市場:目前的趨勢 (全20件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0510EPD

GlobalData's Medical Devices sector report, "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Respiratory Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Respiratory Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Respiratory Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Respiratory Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Respiratory Assist Devices Overview 6

3 Products under Development 7

  • 3.1 Respiratory Assist Devices - Pipeline Products by Stage of Development 7
  • 3.2 Respiratory Assist Devices - Pipeline Products by Segment 8
  • 3.3 Respiratory Assist Devices - Pipeline Products by Territory 9
  • 3.4 Respiratory Assist Devices - Pipeline Products by Regulatory Path 10
  • 3.5 Respiratory Assist Devices - Pipeline Products by Estimated Approval Date 11
  • 3.6 Respiratory Assist Devices - Ongoing Clinical Trials 12

4 Respiratory Assist Devices - Pipeline Products under Development by Companies 13

  • 4.1 Respiratory Assist Devices Companies - Pipeline Products by Stage of Development 13
  • 4.2 Respiratory Assist Devices - Pipeline Products by Stage of Development 14

5 Respiratory Assist Devices Companies and Product Overview 15

  • 5.1 Advanced Respiratory Technologies LLC Company Overview 15
    • 5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 ALung Technologies Inc Company Overview 16
    • 5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Breethe, Inc. Company Overview 21
    • 5.3.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Case Western Reserve University Company Overview 22
    • 5.4.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 enmodes GmbH Company Overview 23
    • 5.5.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 Haemair Ltd Company Overview 24
    • 5.6.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 Liberate Medical, LLC Company Overview 25
    • 5.7.1 Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Lung Biotechnology PBC Company Overview 26
    • 5.8.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 McGowan Institute for Regenerative Medicine Company Overview 27
    • 5.9.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 MedArray Inc. Company Overview 29
    • 5.10.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.11 Merit Medical Systems Inc Company Overview 30
    • 5.11.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 Michigan Critical Care Consultants, Inc. Company Overview 32
    • 5.12.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Miromatrix Medical Inc Company Overview 33
    • 5.13.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.14 Pneumedicare Ltd. Company Overview 34
    • 5.14.1 Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.15 Rice University Company Overview 35
    • 5.15.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.16 The Charles Stark Draper Laboratory Inc Company Overview 36
    • 5.16.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.17 University of Arizona Company Overview 37
    • 5.17.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.18 University of California Los Angeles Company Overview 38
    • 5.18.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.19 University of California San Francisco Company Overview 39
    • 5.19.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.20 University of Kansas Company Overview 40
    • 5.20.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.21 University of Michigan Company Overview 41
    • 5.21.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.22 University of Pittsburgh Company Overview 42
    • 5.22.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.23 Xenios AG Company Overview 43
    • 5.23.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 43

6 Respiratory Assist Devices- Recent Developments 45

  • 6.1 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 45
  • 6.2 Nov 07, 2017: Inogen Announces Record Third Quarter 2017 Financial Results 45
  • 6.3 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 47
  • 6.4 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market 49
  • 6.5 Sep 06, 2017: MGC Diagnostics Reports Fiscal 2017 Third Quarter Results 50
  • 6.6 Sep 05, 2017: Soleno Therapeutics Announces CFO Transition 51
  • 6.7 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 52
  • 6.8 Aug 03, 2017: Inogen Announces Record Second Quarter 2017 Financial Results 54
  • 6.9 Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President's Emergency Plan for AIDS Relief Addiction Technology Transfer Centers 56
  • 6.10 Jun 20, 2017: Holaira Announces Company Name Change to Nuvaira 56
  • 6.11 Jun 02, 2017: Inogen Secures Additional Facility to Support Direct-to-Consumer Sales Growth 57
  • 6.12 Jun 01, 2017: MGC Diagnostics Reports Fiscal 2017 Second Quarter Results 57
  • 6.13 May 11, 2017: Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results 60
  • 6.14 May 09, 2017: Inogen Announces First Quarter 2017 Financial Results 61
  • 6.15 May 04, 2017: Teleflex Reports First Quarter 2017 Results 63
  • 6.16 May 01, 2017: New Lung Support Technology Ras-Q Wins Emerging Medical Innovation Valuation Competition In Minneapolis 64
  • 6.17 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS 65
  • 6.18 Mar 15, 2017: Capnia Reports Fourth Quarter and Full Year 2016 Financial Results 66
  • 6.19 Mar 07, 2017: MGC Diagnostics Reports Fiscal 2017 First Quarter Results 67
  • 6.20 Feb 28, 2017: Inogen Announces Fourth Quarter and Full Year 2016 Financial Results and Updates 2017 Guidance 68
  • 6.21 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 71
  • 6.22 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 71

7 Appendix 74

  • 7.1 Methodology 74
  • 7.2 About GlobalData 77
  • 7.3 Contact Us 77
  • 7.4 Disclaimer 77

List of Tables

1.1 List of Tables

  • Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development 7
  • Table 2: Respiratory Assist Devices - Pipeline Products by Segment 8
  • Table 3: Respiratory Assist Devices - Pipeline Products by Territory 9
  • Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path 10
  • Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date 11
  • Table 6: Respiratory Assist Devices - Ongoing Clinical Trials 12
  • Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development 13
  • Table 8: Respiratory Assist Devices - Pipeline Products by Stage of Development 14
  • Table 9: Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: Pulmonary Assist Device - Product Status 15
  • Table 11: Pulmonary Assist Device - Product Description 15
  • Table 12: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: Hattler Catheter - Product Status 16
  • Table 14: Hattler Catheter - Product Description 16
  • Table 15: Hemolung RAS - Product Status 17
  • Table 16: Hemolung RAS - Product Description 17
  • Table 17: ALung Technologies Inc - Ongoing Clinical Trials Overview 18
  • Table 18: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support 19
  • Table 19: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 19
  • Table 20: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 19
  • Table 21: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 20
  • Table 22: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 23: OXY-1 - Product Status 21
  • Table 24: OXY-1 - Product Description 21
  • Table 25: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 26: Portable Artificial Lung - Product Status 22
  • Table 27: Portable Artificial Lung - Product Description 22
  • Table 28: enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 29: RAS-Q - Product Status 23
  • Table 30: RAS-Q - Product Description 23
  • Table 31: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 32: Portable Artificial Lung - Product Status 24
  • Table 33: Portable Artificial Lung - Product Description 24
  • Table 34: Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 35: VentFree - Product Status 25
  • Table 36: VentFree - Product Description 25
  • Table 37: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 38: Implantable Artificial Lung - Product Status 26
  • Table 39: Implantable Artificial Lung - Product Description 26
  • Table 40: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 41: Biohybrid Artificial Lung - Product Status 27
  • Table 42: Biohybrid Artificial Lung - Product Description 27
  • Table 43: Chronic Artificial Lung - Product Status 28
  • Table 44: Chronic Artificial Lung - Product Description 28
  • Table 45: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Status 28
  • Table 46: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Description 28
  • Table 47: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 48: Artificial Lung Fiber - Product Status 29
  • Table 49: Artificial Lung Fiber - Product Description 29
  • Table 50: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 51: Elation Pulmonary Balloon Dilation Catheter - Product Status 30
  • Table 52: Elation Pulmonary Balloon Dilation Catheter - Product Description 31
  • Table 53: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 54: BioLung - Product Status 32
  • Table 55: BioLung - Product Description 32
  • Table 56: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 57: Miromatrix Artificial Lung - Product Status 33
  • Table 58: Miromatrix Artificial Lung - Product Description 33
  • Table 59: Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 60: Pneumonitor - Product Status 34
  • Table 61: Pneumonitor - Product Description 34
  • Table 62: Rice University Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 63: Respiratory Assist Device - Product Status 35
  • Table 64: Respiratory Assist Device - Product Description 35
  • Table 65: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 66: Silicone-Based Microfluidic Artificial Lung - Product Status 36
  • Table 67: Silicone-Based Microfluidic Artificial Lung - Product Description 36
  • Table 68: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 69: HeCOS - Product Status 37
  • Table 70: HeCOS - Product Description 37
  • Table 71: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 72: Percutaneous Catheter for Lung Assist Device - Product Status 38
  • Table 73: Percutaneous Catheter for Lung Assist Device - Product Description 38
  • Table 74: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 75: Neonatal ECMO Device - Product Status 39
  • Table 76: Neonatal ECMO Device - Product Description 39
  • Table 77: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 78: VestibuGLIDE System - Product Status 40
  • Table 79: VestibuGLIDE System - Product Description 40
  • Table 80: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 81: M-Lung - Product Status 41
  • Table 82: M-Lung - Product Description 41
  • Table 83: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 84: Paracorporeal Ambulatory Assist Lung - Product Status 42
  • Table 85: Paracorporeal Ambulatory Assist Lung - Product Description 42
  • Table 86: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 87: i-lung - Product Status 43
  • Table 88: i-lung - Product Description 43
  • Table 89: Xtralung - Product Status 44
  • Table 90: Xtralung - Product Description 44
  • Table 91: Glossary 76
Back to Top